Tennessee to ask for Medicaid block granting

Amy Baxter | | Health Exec | Policy & Regulations
physician payment concept image

Tennessee is poised to become the first state of the union to ask for Medicaid block granting from the Trump administration, Politico reported. Block granting, which is a lump sum for states to provide healthcare services, represents a major overhaul of the Medicaid program and has been a mainstay of the Republican platform for the last several years.

Tennessee lawmakers approved a bill that requires the state to submit a grant to the Trump administration for a block grant plan within six months.

Proponents of block granting say the financial structure allows states more freedom to provide healthcare services and improve patient outcomes. Opponents argue block grants result in less funding for beneficiaries overall.

The state’s action underscores the Trump administration’s promise to offer more flexibility to states to run Medicaid programs. The administration began allowing states to implement work requirement programs in Medicaid last year.

See the full story below:

Tennessee will ask Trump to OK first Medicaid block grant

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Veterans Affairs denies it discriminates based on politics, marital status
Dexcom recalls more than 2 million CGM receivers over safety issues—dozens of adverse events reported
Ivenix infusion kits recalled by FDA due to serious manufacturing defect
FDA recalls pediatric breathing kits after eight serious injuries
Judge rips Trump administration for terminating DEI-advancing NIH grants: ‘Have we no shame?’
FDA recalls Zyno infusion pumps, citing risk of death

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.